Studies on the seroprevalence, age, and gender on the distribution of feline coronavirus in Van cats kept in a multiple-cat environment

• Autorzy: Akkan H A , Karaca M.
• Języki publikacji: EN

Abstrakty

EN

In the present study, we aimed to investigate for the first time the seroprevalence of feline coronaviruses (FCoV) in Van cats kept in a multiple-cat environment. A total of 24 male and 46 female Van cats aged between two months and nine years were used in the study. FCoV antibodies were determined using the commercial feline coronavirus antibody ELISA kit. The cats were examined clinically before blood sampling. No clinical signs of feline infectious peritonitis diseases were observed in the cats. But, out of the 70 cats, 38 (54.3%) showed seropositivity to FCoV. When the results were examined with regard to gender, 28 (60.9%) of female cats, and 10 (41.7%) of male cats were seropositive. When the results were examined with regard to age, out of the 18 cats aged between two months and one year, three (16%) were seropositive, out of the 10 cats aged between one to two years - eight (80%), out of the 27 cats aged between two to five years - 15 (55.5%), out of the 13 cats aged between five to eight years - 11 (84%), and all cats (two) aged over eight years showed seropositive reaction to FCoV.

Słowa kluczowe

EN

seroprevalence; age; gender; distribution; feline coronavirus; Coronaviridae; virus category; Van cat; male; female; peritonitis; multiple-cat environment; antibody; diagnosis; animal disease

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2009
• Tom: 53
• Numer: 2
• Opis fizyczny: p.183-186,ref.

Twórcy

autor

Akkan H A

• Yuzuncu Yil University, 65080 Van, Turkey

autor

Karaca M.

Bibliografia

• 1. Baneth G., Kass P.H., Steinfeld D., Beser M.: A seroepidemiological study of feline coronavirus, feline immunodeficiency virus and feline leukemia virus among cats in Israel. Isr Vet Med Assoc 1999, 54, 2, (http://www.isrvma.org/article/54_2_3.htm).
• 2. Barlough J.E., Shacklett B.L.: Antiviral studies of feline infectious peritonitis virus in vitro. Vet Rec 1994, 20, 177-179.
• 3. Benetka V., Kübber-Heiss A., Kolodziejek J., Nowotny N., Hofmann-Parisot M., Möstl K.: Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet Microbiol 2004, 99, 31-42.
• 4. Binder C., Hartmann K.: Klinik der felinen infektiösen Peritonitis. 9. Jahrestagung der Fachgruppe, Innere Medizin und klinische Laboratoriumdiagnostik, Deutche Veterinarmedizinsche Gesellschaft e.V., München, 2000.
• 5. Börkü M.K., Kurtdede A., Durgut R., Pekkaya S.: Feline infectious peritonitis in a Van cat. YYÜ Sağ Bil Derg 2001, 7, 4-6.
• 6. Duthie S., Eckersal P.D., Addie D.D., Lawrence C.E., Jarret O.: Value of α1-acid glycoprotein in the diagnosis of feline infectious peritonitis. Vet Rec 1997, 20, 299- 303.
• 7. Everman J.F., Henry C.J., Marks S.L.: Feline infectious peritonitis. J Am Vet Med Assoc 1995, 206, 1130-1134.
• 8. Foley J.E., Poland A., Carlson J., Pedersen N.C.: Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus. J Am Vet Med Assoc 1997, 210, 1313- 1318.
• 9. Foley J.E., Rand C., Leutenegger C.: Inflammation and changes in cytokine levels in neurological feline infectious peritonitis. J Feline Med Surg 2003, 5, 313- 322.
• 10. German A.C., Helps C.R., Harbour D.A.: FIP: a novel approach to vaccination. Proc 2nd Int FCoV/FIP Symp, Glasgow, 2002. J Feline Med Surg 2004, 6, 119-124.
• 11. Gunn-Moore D.A., Gruffydd-Jones T.J., Harbour D.A.: Detection of feline coronaviruses by culture and reverse transcriptase-polymerase chain reaction of blood samples from healthy cats and cats with clinical feline infectious peritonitis. Vet Microbiol 1998, 62, 193-205.
• 12. Herrewegh A.A.P.M., Mahler M., Hedrich H.J., Haagmans B.L., Egberink H.F., Horzinek M.C., Rottier P.J.M., De Groot R.J.: Persistence and evolution of feline coronavirus in a closed cat-breeding colony. Virology 1997, 234, 349-363.
• 13. Hohdatsu T., Okada S., Ishizuka Y., Yamada H., Koyama H.: The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci 1992, 54, 557-562.
• 14. Ishida T., Shibanai A., Tanaka S., Uchida K., Mochizuki M.: Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis. J Feline Med Surg 2004, 6, 107-109.
• 15. Kennedy M., Kania S., Stylianides E., Bertschinger H., Keet D., Van Vuuren M.: Detection of feline coronavirus infection in Southern African nondomestic felids. J Wildl Dis 2003, 39, 529-535.
• 16. Kiss I., Kecskemeti S., Tanyi J., Klingeborn B., Belak S.: Prevalence and genetic pattern of feline coronaviruses in urban cat population. Vet J 2000, 159, 64-70.
• 17. Paltrinier S., Cammarata M.P., Cammarata G., Comazzi S.: Some aspects of humoral and cellular immunity in naturally occurring feline infectious peritonitis. Vet Immunol Immunopathol 1998, 65, 205-220.
• 18. Paltrinieri S., Greico V., Comazzi S., Parodi M.C.: Laboratory profiles in cats with different pathological and immunohistochemical findings due to feline infectious peritonitis (FIP). J Feline Med Surg 2001, 3, 149-159.
• 19. Paltrinieri S.: Human severe acute respiratory syndrome (SARS) and feline coronaviruses. J Feline Med Surg 2004, 6, 131-132.
• 20. Poltkay S., Bacher J.D., Pitts T.W.: Feline infectious peritonitis in a closed breeding colony. Lab Anim Sci 1974, 24, 279-289.
• 21. Posch A., Posch U., Kübber-Heiss A., Seiser M., Moestl K.: Differentiation of feline coronaviruses type I and II strains by RT-PCR. Proceeding of WSAVA World Veterinary Congress, Lyon, 1999.
• 22. Vennema H., Poland A., Foley J., Pedersen N.C.: Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 1998, 243, 150-157.